Last reviewed · How we verify

NCT00405288

The Safety of Proctofoam-HC in the Third Trimester of Pregnancy

Completed Results posted Last updated 3 January 2014
What this trial tests

trial testing Proctofoam-HC® in Hemorrhoids in 408 participants. Completed in 1 June 2010.

Timeline
1 November 2006
Primary endpoint
1 November 2009
1 June 2010

Quick facts

Lead sponsorThe Hospital for Sick Children
StatusCompleted
Study typeOBSERVATIONAL
Enrollment408
Start date1 November 2006
Primary completion1 November 2009
Estimated completion1 June 2010
Sites2 locations across Canada

Drugs / interventions tested

Conditions studied

Sponsor

The Hospital for Sick Children

Who can join

18 and older, female only, with Hemorrhoids or Pregnancy. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose of this study is to evaluate the fetal safety of topical application of Proctofoam-HC®, an antihemorrhoidal, in the third trimester of pregnancy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hemorrhoids

Currently open trials in the same condition.

Other The Hospital for Sick Children trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00405288.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing